Artboard 33 Artboard 16 Artboard 18 Artboard 15 Artboard 21 Artboard 1 Artboard 2 Artboard 5 Artboard 45 Artboard 45 Artboard 22 Artboard 9 Artboard 23 Artboard 17? Artboard 28 Artboard 43 Artboard 49 Artboard 47 Artboard 38 Artboard 32 Artboard 8 Artboard 22 Artboard 5 Artboard 25 Artboard 1 Artboard 42 Artboard 11 Artboard 41 Artboard 13 Artboard 23 Artboard 10 Artboard 4 Artboard 9 Artboard 20 Artboard 6 Artboard 11 Artboard 7 Artboard 3 Artboard 3 Artboard 12 Artboard 25 Artboard 34 Artboard 39 Artboard 24 Artboard 13 Artboard 19 Artboard 7 Artboard 24 Artboard 31 Artboard 4 Artboard 14 Artboard 27 Artboard 30 Artboard 36 Artboard 44 Artboard 12 Artboard 17 Artboard 17 Artboard 6 Artboard 27 Artboard 19 Artboard 30 Artboard 29 Artboard 29 Artboard 26 Artboard 18 Artboard 2 Artboard 20 Artboard 35 Artboard 15 Artboard 14 Artboard 48 Artboard 50 Artboard 26 Artboard 16 Artboard 40 Artboard 21 Artboard 29 Artboard 10 Artboard 37 Artboard 3 Artboard 3 Artboard 46 Artboard 8

Cytotoxic Anticancer Drugs (Cód: 6106573)

Frederick Valeriote; Thomas H. Corbett; Laurence H. Baker

SPRINGER VERLAG POD

Ooopss! Este produto está temporariamente indisponível.
Mas não se preocupe, nós avisamos quando ele chegar.

Ooops! Este produto não está mais a venda.
Mas não se preocupe, temos uma versão atualizada para você.

Ooopss! Este produto está fora de linha, mas temos outras opções para você.
Veja nossas sugestões abaixo!

R$ 2.561,90 em até 10x de R$ 256,19 sem juros
Cartão Saraiva R$ 2.433,81 (-5%) em até 1x no cartão ou em até 15x de R$ 170,79 sem juros

Crédito:
Boleto:
Cartão Saraiva:

Total: R$0,00

Em até 10x sem juros de R$ 0,00


Cytotoxic Anticancer Drugs

R$2.561,90

Descrição

The focus of the 22nd Annual Detroit Cancer Symposium was the presentation and discussion of cytotoxic agents, with a significant portion of the symposium including the exciting frontiers of drug discovery being
explored by the National Cooperative Drug Discovery Groups (NCDDG) Program. The symposium brought together a large number of investigators from government, universities and pharmaceutical companies involved in the discovery
and development of new anticancer agents. Exciting new leads were presented and the status of others presently under development was discussed. Of particular significance has been the initiation of renewed
efforts in the area of natural product drug discovery, where the discovery of new cytotoxics is very promising at the moment. A number of major changes have occurred during the last decade in research on drug discovery of
cytotoxic agents. Critical reviews of a number of the models and concepts underlying drug discovery represented a continuous thread throughout the meeting, being constantly discussed in terms of their advantages,
disadvantages and capabilities of discovering solid tumor active anticancer agents. A recent development which is to be much applauded and which portends to great discoveries is the new relationship formed
between Government, University of Industry. The NCDDG mechanism which stimulates this interaction is an inexpensive manner to greatly magnify the drug discovery and development effort nationally. Cytotoxic
Anticancer Drugs: Models and Concepts for Drug Discovery and Development represents a forum which will become the major mode for bringing together these three different components in the
equation to regularly discuss new results and ideas.

Características

Produto sob encomenda Sim
Marca SPRINGER VERLAG POD
Cód. Barras 9780792316299
Altura 23.40 cm
I.S.B.N. 9780792316299
Profundidade 2.38 cm
Referência 9780792316299
Ano da edição 1992
Idioma Inglês
Número de Páginas 428
Peso 0.45 Kg
Largura 15.60 cm
AutorFrederick Valeriote; Thomas H. Corbett; Laurence H. Baker

Avaliações

Avaliação geral: 0

Você está revisando: Cytotoxic Anticancer Drugs